SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,692.49 -71.74
( -0.10%)

Global Indices

Nasdaq

52,403.42 -403.65
(-0.76%)

Dow Jones

7,657.83 -36.69
(-0.48%)

Hang Seng

65,089.68 -179.65
(-0.28%)

Nikkei 225

10,664.98 -146.68
(-1.36%)

Forex

USD-INR

94.74 0.23
(0.24%)

EUR-INR

110.11 0.28
(0.26%)

GBP-INR

128.27 0.39
(0.30%)

JPY-INR

0.62 0.01
(0.94%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Lyka Labs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500259

INE933A01014

24.1923243

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LYKALABS

300.54

EPS(TTM)

Face Value()

Div & Yield %

Back

novartis india ltd

Novartis India standalone net profit rises 16.62% in the June 2026 quarter

Jul 23,2026

Net profit of Novartis India rose 16.62% to Rs 32.21 crore in the quarter ended June 2026 as against Rs 27.62 crore during the previous quarter ended June 2025. Sales rose 18.57% to Rs 103.81 crore in the quarter ended June 2026 as against Rs 87.55 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	103.81	87.55	19
OPM %	33.63	31.11	-
PBDT	43.59	37.75	15
PBT	43.17	37.22	16
NP	32.21	27.62	17

74,692.49 -71.74 ( -0.10%)

52,403.42 -403.65 (-0.76%)

7,657.83 -36.69 (-0.48%)

65,089.68 -179.65 (-0.28%)

10,664.98 -146.68 (-1.36%)

94.74 0.23 (0.24%)

110.11 0.28 (0.26%)

128.27 0.39 (0.30%)

0.62 0.01 (0.94%)